Los Angeles Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-16,169
| Closed | -$785K | – | 1107 |
|
2024
Q3 | $785K | Buy |
+16,169
| New | +$785K | ﹤0.01% | 729 |
|
2024
Q2 | – | Sell |
-17,428
| Closed | -$765K | – | 1169 |
|
2024
Q1 | $765K | Hold |
17,428
| – | – | ﹤0.01% | 766 |
|
2023
Q4 | $1.08M | Sell |
17,428
-10,015
| -36% | -$619K | ﹤0.01% | 653 |
|
2023
Q3 | $1.26M | Buy |
27,443
+358
| +1% | +$16.5K | 0.01% | 563 |
|
2023
Q2 | $1.56M | Buy |
27,085
+610
| +2% | +$35.1K | 0.01% | 545 |
|
2023
Q1 | $993K | Buy |
26,475
+16,475
| +165% | +$618K | ﹤0.01% | 673 |
|
2022
Q4 | $280K | Sell |
10,000
-1,755
| -15% | -$49.2K | ﹤0.01% | 1055 |
|
2022
Q3 | $330K | Hold |
11,755
| – | – | ﹤0.01% | 1046 |
|
2022
Q2 | $409K | Buy |
11,755
+6,120
| +109% | +$213K | ﹤0.01% | 1040 |
|
2022
Q1 | $202K | Buy |
+5,635
| New | +$202K | ﹤0.01% | 1357 |
|
2016
Q4 | – | Sell |
-14,105
| Closed | -$268K | – | 1159 |
|
2016
Q3 | $268K | Buy |
14,105
+520
| +4% | +$9.88K | ﹤0.01% | 1085 |
|
2016
Q2 | $219K | Sell |
13,585
-1,450
| -10% | -$23.4K | ﹤0.01% | 1134 |
|
2016
Q1 | $180K | Buy |
+15,035
| New | +$180K | ﹤0.01% | 1069 |
|